Immunocore Holdings (IMCR) Asset Utilization Ratio (2022 - 2026)

Immunocore Holdings (IMCR) has reported Asset Utilization Ratio for 4 consecutive years, with 0.39 the latest figure, recorded in Q1 2026.

• Quarterly Asset Utilization Ratio rose 17.86% year-over-year to 0.39 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.39 (up 17.86% YoY) and the FY2025 annual result came in at 0.39, changed 0.25% from the prior year.
• Asset Utilization Ratio improved to 0.39 in Q1 2026 per IMCR's latest filing, from 0.37 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for IMCR reached as high as 0.39 in Q1 2026 and fell as low as 0.28 in Q2 2024.
• A 4-year average of 0.33 and a median of 0.33 in 2024 frame the typical range for Asset Utilization Ratio.
• The largest YoY upside for Asset Utilization Ratio was 24.46% in 2025 against a maximum downside of 1.81% in 2025.
• Year by year, Asset Utilization Ratio stood at 0.3 in 2022, then decreased by 0.53% to 0.3 in 2024, then increased by 24.46% to 0.37 in 2025, then advanced by 4.67% to 0.39 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.39, 0.37, and 0.35 for Q1 2026, Q4 2025, and Q3 2025 respectively.